Jung-Min Ahn , MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. TAVR for Bicuspid AS: Optimal Sizing & Valve Selection
  2. Imaging-guided PSP for Optimizing PCI
  3. How to Treat Tandem Lesion Under Physiology-Guidance
  4. Guide Extension Catheters: Strong Support from Mother-Child Relationship
  5. Post TAVR Coronary Access with Evolut System
  6. Self-Expandable Evolut R & PRO Valve
  7. TAVR for Bicuspid AV: Tips and Tricks
  8. Bifurcation PCI: Contemporary Practical Approach
  9. The Role of Debulking Atherectomy for Calcific In-stent Restenosis
  10. Prognosis of Discordant Lesion Between FFR and Hyperemia Free Indexes
  11. [Case-based Debate: Intracoronary Imaging Modalities for PCI Guidance] IVUS Is Better!
  12. Clinically Relevant PeriProcedural MI: Practical and Clinical Trial Aspect
  13. Case 1: Unexpanded ISR - Challenging and Optimal Treatment
  14. How Do I Implement?: FFR and Various Non-hyperemic Diastolic Index
  15. Current Status of Balloon-Expandable TAVR in Korea
  16. OAC in TAVR: FAILED GALILEO - NOAC Don\'t Work or Other Options?
  17. TAVR for Bicuspid AV: Tips and Tricks
  18. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  19. Guide Extension Catheters: A Strong Support from a Parent-Child Relationship
  20. Expert Case Review: Complex PCI for Severe Calcified Coronary Disease
  21. Expert Case Review: Complex Bifurcation PCI
  22. Impact of Renal Function on Stroke or Systemic Embolism Following TAVR
  23. TAVR for Bicuspid Valve: Clinical Outcome and Technical Considerations
  24. TAVR: Bicuspid, Severe Calcium, and Low Lying Left Main
  25. TAVR in Bicuspid Aortic Stenosis with Severe Calcification: Case Reviews and Tips-and-Tricks
  26. How About Integrated Use of Resting Pd/Pa and FFR?
  27. Distal Left Main Bifurcation PCI: Concept Is More Important.
  28. [Case #2: Transcatheter Aortic Valve Implantation in a Patient with Type B Aortic Dissection] Part 2. How Would I Treat?
  29. FFR as the Gold Standard Index!
  30. Five-Year Outcomes of Routine FFR Use in Clinical Practice: Data from ASAN PCI Registry
  31. The Benefit of Complete Revascularization in Complex Coronary Artery Disease
  32. Asian Pacific TAVR Registry
  33. [Taped Case] TAVR with Evolut R
  34. Bicuspid AS: Future Perspectives of TAVR
  35. Integrated Use of FFR and IVUS for LM PCI
  36. Bicuspid TAVR Registry and TRANSIT Trial: TAVI Experience in AMC
  37. Bicuspid and Valve-in-Valve; How Different?
  38. Clinical Outcome of DEFER
  39. Left Main and MVD PCI: Imaging and Functional Guidance
  40. Utility of Intravascular Imaging for Resolving Issues During PCI
  41. Long Lesion and Tandem Lesion
  42. Bicuspid TAVR Registry
  43. AP TAVR Registry
  44. Current Status of TAVR: High/Intermediate and Lower Risk
  45. Clinical Impact of Routine FFR Measurement
  46. Tandem
  47. Prognostic Value of FFR: Insight from IRIS-FFR Registry
  48. Practical Aspect of IMR in AMI and Stable Angina
  49. Fate of FFR-Guided Deferral Data from IRIS-FFR Registry
  50. Elderly Population
  51. LM PCI 2016: Integrated Approach Using IVUS, FFR and New Imaging Modality
  52. [Review in 2015] Physiology
  53. Tandem Lesion Evaluation
  54. Integrated Use of IVUS and FFR in Real Practice
  55. Readmission After PCI or CABG
  56. Left Main
  57. Final Answer RESTORE
  58. Comparative Outcomes of Various DES from IRIS-MAIN Registry and PRECOMBAT Series
  59. Case Presentation 4: Medically Stabilized Type A Aortic Dissection After TAVI
  60. Randomzed Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: Five-Year Outcomes of the PRECOMBAT Study
  61. Preliminary Data from IRIS FFR Registry
  62. Complex Lesions, Left Main, Bifurcations, Tandem, and More
  63. Left Main PCI
  64. Understanding About Visual-Functional Mismatching
  65. TAVI for Bicuspid Valve Stenosis
  66. FFR-guided PCI in Routine Practice: Learn from AMC Experiences
  67. Is There a Generation Gap of DES: Results of PRECOMBAT Study Series
  68. Comparison of Coronary Bypass Surgery with Drug-eluting Stenting for the Treatment of Left Main Disease: 3-year Follow-up of the PRECOMBAT Trial
  69. Clinical Implementation of FFR
  70. Case-based Review: Incidence and Treatment of LM ISR
  71. LM & Tandem Lesion
  72. VH IVUS: Native Plaque and Neointima
  73. Clinical Evidence of Neoatherosclerosis: ISR and Late Stent Thrombosis
  74. LM PCI
  75. IRIS-ELEMENT Data Review
  76. Cross and Perfect: 2013 Update
  77. Comparison of Platinum Chromium Versus Cobalt Chromium Everolimus-eluting Stent in Real World Practice: Outcomes from the Multicenter Prospective IRIS-DES Registry
  78. Anatomical - Functional Stenosis: How Much Discordant?
  79. Case Presentation: Functional Angioplasty
  80. Impact of Functional Angioplasty on Clinical Outcomes of PCI
  81. Novice's Trial of Complex LM PCI
  82. New-generation DES for Long Lesions: From a Large-scale Cohort Regis
  83. FFR Utilization in LM PCI
  84. Promus Element Clinical Program in Asan Medical Center
  85. FFR-guided PCI in Tandem Lesion
  86. Two Cases with Coronary Thromboembolism
  87. FFR Guided Functional Angioplasty
  88. Does the Timing of IABP Matter?